Table of Content

1 Market Introduction
1.1 Market Definition
1.2 Research Scope and Segmentation
1.3 Stakeholders
1.4 List of Abbreviations


2 Executive Summary


3 Research Methodology
3.1 Identification of Data
3.2 Data Analysis
3.3 Verification
3.4 Data Sources
3.5 Assumptions


4 Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges


5 Porter’s Five Force Analysis
5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Buyers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry in the Market


6 Global Oncology Precision Medicine Market by, Type of Cancer
6.1 Overview
6.2 Skin Cancer
6.3 Lung Cancer
6.4 Head and Neck Squamous Cell Cancer
6.5 Gastrointestinal Cancer
6.6 Cervical Cancer
6.7 Breast Cancer
6.8 Blood / Hematologic Cancer
6.9 Bladder Cancer
6.10 Other Type of Cancers


7 Global Oncology Precision Medicine Market by, Type of Molecule
7.1 Overview
7.2 Small Molecules
7.3 Biologics


8 Global Oncology Precision Medicine Market by, Route of Administration
8.1 Overview
8.2 Oral
8.3 Intravenous
8.4 Other Route of Administrations


9 Global Oncology Precision Medicine Market by, Drug Class
9.1 Overview
9.2 Kinase Inhibitors
9.3 Enzyme Inhibitors
9.4 Immune Checkpoint Inhibitors
9.5 Other Drug Classes


10 Global Oncology Precision Medicine Market by, Geography
10.1 Overview
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 UK
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Australia
10.4.6 New Zealand
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 UAE
10.6.2 Saudi Arabia
10.6.3 Qatar
10.6.4 Iran
10.6.5 South Africa
10.6.6 Rest of Middle East & Africa


11 Key Developments


12 Company Profiling
12.1 Abbott Laboratories
12.1.1 Business Overview
12.1.2 Product/Service Offering
12.1.3 Financial Overview
12.1.4 SWOT Analysis
12.1.5 Key Activities
12.2 Agilent Technologies, Inc.
12.3 Almac Group Ltd
12.4 AstraZeneca
12.5 BGI Group
12.6 Bio-Rad Laboratories, Inc
12.7 F. Hoffmann-La Roche Ltd
12.8 Illumina, Inc
12.9 Merck
12.10 Novartis AG
12.11 Roche
12.12 Thermo Fisher Scientific Inc